Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;98:626-634
Published online before print February 2, 2006, doi: 10.1161/01.RES.0000207407.51752.3c
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
98/5/626    most recent
01.RES.0000207407.51752.3cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujita, H.
Right arrow Articles by Kume, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujita, H.
Right arrow Articles by Kume, T.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
*Genetics Home Reference
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Arterial thrombosis
Right arrow Coagulation
Right arrowRelated Article
(Circulation Research. 2006;98:626.)
© 2006 American Heart Association, Inc.


Molecular Medicine

Foxc2 Is a Common Mediator of Insulin and Transforming Growth Factor ß Signaling to Regulate Plasminogen Activator Inhibitor Type I Gene Expression

Hideo Fujita, Myengmo Kang, Mesut Eren, Linda A. Gleaves, Douglas E. Vaughan, Tsutomu Kume

From the Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn.

Correspondence to Tsutomu Kume, PhD, Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, 332 PRB, 2220 Pierce Ave, Nashville, TN 37232-6300. E-mail tsutomu.kume{at}vanderbilt.edu

Elevated plasma levels of plasminogen activator inhibitor type I (PAI-1), a significant risk factor of ischemic heart disease, are associated with insulin resistance in which insulin and transforming growth factor (TGF)-ß play a pivotal role in regulating PAI-1 production. Forkhead transcription factor FOXC2 is an important regulator of insulin resistance. However, the underlying molecular mechanisms to link FOXC2 to PAI-1 levels in insulin resistance remain to be elucidated. Here, we demonstrate that Foxc2 is a common transcriptional activator of insulin and TGF-ß signaling to directly regulate PAI-1 expression via 2 distinct target sites, an insulin response element (IRE) and a novel forkhead-binding element (FBE), adjacent to a Smad-binding site. We found that in adipocytes and endothelial cells Foxc2 mediates insulin action competing with another Forkhead protein, FOXO1, via the insulin response element, and simultaneously cooperate with the TGF-ß/Smad pathway to transactivate PAI-1. Importantly, Foxc2 haploinsufficiency in mice significantly attenuates TGF-ß1–induced PAI-1 expression in the cardiovascular system and adipose tissue. Taken together, we propose that Foxc2 is a key molecule to regulate PAI-1 gene expression.


Key Words: plasminogen activator inhibitor-1 promoter • insulin response element • TGF-ß • response site • forkhead transcription factor


Related Article:

Five Easy Pieces: The Obesity Paradigm
Nageswara R. Madamanchi and Marschall S. Runge
Circ. Res. 2006 98: 576-578. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
U. R. Jag, J. Zavadil, and F. M. Stanley
Insulin Acts through FOXO3a to Activate Transcription of Plasminogen Activator Inhibitor Type 1
Mol. Endocrinol., October 1, 2009; 23(10): 1587 - 1602.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Li, J. J. Shen, J. C. Bournat, L. Huang, A. Chattopadhyay, Z. Li, C. Shaw, B. H. Graham, and C. W. Brown
Activin Signaling: Effects on Body Composition and Mitochondrial Energy Metabolism
Endocrinology, August 1, 2009; 150(8): 3521 - 3529.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. Ruano, J. Lopez-Miranda, R. de la Torre, J. Delgado-Lista, J. Fernandez, J. Caballero, M. I. Covas, Y. Jimenez, P. Perez-Martinez, C. Marin, et al.
Intake of phenol-rich virgin olive oil improves the postprandial prothrombotic profile in hypercholesterolemic patients
Am. J. Clinical Nutrition, August 1, 2007; 86(2): 341 - 346.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M.-C. Alessi and I. Juhan-Vague
PAI-1 and the Metabolic Syndrome: Links, Causes, and Consequences
Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): 2200 - 2207.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. R. Madamanchi and M. S. Runge
Five Easy Pieces: The Obesity Paradigm
Circ. Res., March 17, 2006; 98(5): 576 - 578.
[Full Text] [PDF]